Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
02/23/2005 | CN1190428C Herbicides of substituted phenyl oxazolidinone type |
02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
02/22/2005 | US6858635 Photoreceptive detectors such as 2-(4-(4-((5S)-5-((Acetylamino )methyl)-2-oxo-3-oxazolidinyl)-2-fluorophenyl)-1-piperazinyl)-2-oxoethyl-4 -azido-2-hydroxy-5-iodobenzoate, used for analyzing binding in grampositive and negative bacteria |
02/22/2005 | CA2310778C Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
02/17/2005 | US20050038092 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species; side effect reductions |
02/17/2005 | US20050038090 cytotoxic agents; made by fermentation of Streptomyces sparsogenes |
02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
02/17/2005 | DE10333368A1 Multifunktionell-verknüpfungsfähige und spaltbare Festphasenreagenzien und Verfahren zu deren Herstellung Multi-functional-link-able and cleavable solid phase reagents and methods for their preparation |
02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
02/16/2005 | EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
02/16/2005 | CN1582154A Method for treating or prophylaxis of aldo sterone-medicated phthogenic effects in subjwect using epoxy-steroidal aldosterone antagonist |
02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
02/10/2005 | WO2005012271A2 Process for the synthesis of biaryl oxazolidinones |
02/10/2005 | WO2005012270A2 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
02/10/2005 | WO2005012221A1 Diphenyl ether compound, process for producing the same, and use |
02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
02/10/2005 | US20050033100 Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse |
02/10/2005 | US20050033059 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
02/10/2005 | US20050032859 inhibiting, in mammals, including humans, the production of A beta -peptides that can contribute to the formation of neurological deposits of amyloid protein |
02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
02/10/2005 | US20050029705 Extrusion die |
02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
02/09/2005 | EP1324988B1 Process for the preparation of 5-hydroxymethyl 2-oxazolidinone and novel intermediate |
02/09/2005 | EP1244640B1 Oxazolidinone derivatives |
02/09/2005 | EP1184366B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
02/09/2005 | EP0983999B1 Process for producing amide derivatives and intermediates |
02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
02/08/2005 | US6852892 Process for the synthesis of sphingosine |
02/03/2005 | WO2005009998A1 Pna monomer and precursor |
02/03/2005 | WO2005009981A1 Multifunctional linking and cleavable solid-phase reagents and method for the production thereof |
02/03/2005 | WO2005009951A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
02/03/2005 | WO2004100881A3 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
02/03/2005 | US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds |
02/03/2005 | US20050026943 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
02/03/2005 | US20050026930 1,3,4-Thiadiazole-2-sulfonyl-N-piperazine; 1,3,4-oxadiazole-2-sulfonyl-N-piperazine; oxazole-2-sulfonyl-N-piperazine; or thiazole-2-sulfonyl-N-piperazine derivatives; cyclization, coupling, amidation; peptide synthesis; peptide nucleic acids |
02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
02/03/2005 | CA2533392A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
02/02/2005 | EP1501812A1 Pna monomer and precursor |
02/02/2005 | EP1501509A2 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
02/02/2005 | EP1242395B1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
02/02/2005 | CN1575279A Substituted thioacetamides |
02/02/2005 | CN1573578A Electrophotographic organophotoreceptors with novel charge transport compounds |
02/02/2005 | CN1187345C Method for preparing N-[1-(S)-carbethoxy-3-hydrocinnamyl] -L-alanine-N-carboxy acid anhydride |
02/01/2005 | US6849743 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
02/01/2005 | US6849742 Binaphthol derivative and process for producing the same |
02/01/2005 | US6849741 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin |
02/01/2005 | US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
02/01/2005 | CA2183976C Process for making an epoxide |
01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
01/27/2005 | WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
01/27/2005 | US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
01/27/2005 | US20050020651 Butyric acid derivatives |
01/26/2005 | EP1500655A1 New methionine aminopeptidase inhibitor |
01/26/2005 | EP1499609A2 Pesticidal heterocycles |
01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
01/26/2005 | EP1448058A4 Optically active herbicidal (r)-phenoxypropionic acid-n-methyl-n-2-fluorophenyl amides |
01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
01/25/2005 | US6846838 Ureido-substituted aniline compounds useful as serine protease inhibitors |
01/25/2005 | CA2129455C Orally active azole derivatives |
01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
01/20/2005 | WO2005005420A1 Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof |
01/20/2005 | WO2005005399A1 Oxazolidinone antibiotics and derivatives thereof |
01/20/2005 | WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
01/20/2005 | US20050014870 Containing nucleating agent such as 3,3'-(2-methyl-1,3-phenylene)diimino-bis-4,5,6,7-tetrachloro-1H-isoindole-1-one; accelerating polyester crystallization; reducing molding time; rigidity, transparency |
01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
01/20/2005 | US20050014765 Aryl-heteroaromatic products, compositions comprising them and use |
01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |